Erowid.org: Erowid Reference 7496 : Poisoning from a dietary supplement administered during hospitalization : Boyer EW, Kearney S, Shannon MW, Quang L, Woolf A, Kemper K

Erowid References Database

Boyer EW, Kearney S, Shannon MW, Quang L, Woolf A, Kemper K. “Poisoning from a dietary supplement administered during hospitalization”. Pediatrics. 2002 Mar 04;109(3):E49. <a name="ref">Boyer EW, Kearney S, Shannon MW, Quang L, Woolf A, Kemper K.</a> <a href="/references/7496">"Poisoning from a dietary supplement administered during hospitalization"</a> <i>Pediatrics</i>. 2002 Mar 04;109(3):E49.
Text Abstract (this page) Full Text - English (private) Show Articles by Boyer EW Kearney S Shannon MW Quang L Woolf A Kemper K Article IDs Erowid RefID: 7496 PubMedID: 11875177 Collections Hofmann Collection MDMA Collection All References	Abstract Increasing numbers of persons use dietary supplements DS. Patients who believe in the effectiveness of DS may continue to take them on admission to a health care facility. We present the case of a child who received a DS on a daily basis as an outpatient, continued its use after admission to the hospital, and became poisoned by it during his hospitalization. A laboratory analysis of the patent remedy identified the presence of barbiturates phenobarbital and mephobarbital and calcium, magnesium, sodium, and potassium bromide salts.
Comments and Responses to this Article #
Status: display earth Apr 17, 2011 1:59	Comment # From the paper: 'A laboratory analysis of the patent remedy identified the presence of barbiturates (phenobarbital and mephobarbital) and calcium, magnesium, sodium, and potassium bromide salts. Three months after hospitalization, the child was maintained on phenobarbital and carbamazepine but was suffering approximately 30 seizures per day. He was restarted on bromide therapy for seizure suppression.'
Submit Comment

[ Cite HTML ]